Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
YZR Capital is a venture capital firm founded in 2021 and headquartered in Munich, Germany. The firm was established to support entrepreneurs tackling complex challenges in the healthcare sector. YZR Capital focuses on investing in companies that leverage technology to create scalable solutions aimed at improving patient care, enhancing provider efficiencies, and innovating healthcare value chains.
Currently, YZR Capital manages a fund size of €100 million and has made 32 investments across various healthcare-related sectors. The firm operates with a pan-European mandate, targeting early-stage ventures through to growth equity. Notably, YZR Capital is backed by Growth Fund Germany, a government-supported limited partner, which adds credibility to its investment strategy.
Since its inception, YZR Capital has established itself as a key player in the European healthtech landscape, with a focus on companies that are defining new categories within the healthcare space. The firm’s commitment to improving healthcare outcomes is reflected in its diverse portfolio and active engagement with its investments.
YZR Capital invests in a range of sectors within the healthcare domain, including healthcare, artificial intelligence, biotechnology, and digital health. The firm targets companies at various stages, from pre-seed to growth equity, with a particular emphasis on technology-enabled solutions that address significant healthcare challenges. The check sizes typically align with the stages of investment, allowing for flexibility in supporting startups as they scale.
The firm’s investment thesis revolves around three main pillars: improving patient care, increasing provider efficiency, and innovating healthcare value chains. YZR Capital seeks to partner with ambitious founders who are dedicated to solving complex healthcare issues through scalable and impactful solutions. The firm is particularly interested in areas such as digital health, AI-powered diagnostics, telemedicine, and synthetic biology.
YZR Capital has built a diverse portfolio of 32 companies, focusing on innovative solutions within the healthcare sector. Notable portfolio companies include:
This portfolio reflects YZR Capital's commitment to investing in companies that are not only addressing immediate healthcare challenges but also paving the way for future innovations in the sector.
Prof. Dr. Reinhard Meier — Co-Founder & Managing Partner; a physician-turned-investor with a background in telemedicine, having co-founded Teleclinic, Germany's leading telemedicine platform.
Markus Feuerecker — Co-Founder & Managing Partner; brings experience in venture capital, growth equity, and buyout private equity, contributing to the firm's strategic direction.
Christina Schmidt — Investor; has over five years of experience in venture capital and startups, focusing on identifying promising healthcare innovations.
Till Quitzau — Investor; previously an Associate Consultant at Bain & Company, he brings analytical expertise and strategic insight to the investment process.
To pitch to YZR Capital, founders should use the submission link provided: Submit your Pitch. The firm prefers detailed decks that include information on the problem being solved, the technology involved, market analysis, and the team’s background. Founders should expect a response within a few weeks, and while warm introductions can be beneficial, they are not strictly necessary for submission.
In recent months, YZR Capital has actively engaged with its portfolio companies, highlighting significant developments. Notably, Biorce secured additional funding to accelerate its AI-driven drug development initiatives. Additionally, Scan.com received recognition for its innovative approach to medical imaging, ranking second among healthtech startups in The Sunday Times 100 Tech 2026.
These activities underscore YZR Capital's commitment to supporting its portfolio and contributing to advancements in healthcare innovation. The firm continues to publish insights and updates on its blog, reflecting its active involvement in the healthcare sector.
What are YZR Capital's investment criteria?
YZR Capital focuses on early-stage companies in the healthcare sector, particularly those that leverage technology to improve patient care and provider efficiencies. The firm looks for scalable solutions that address significant healthcare challenges.
How can I apply or pitch to YZR Capital?
Founders can submit their pitch through the provided link: Submit your Pitch. The firm encourages detailed presentations that outline the problem being solved, the technology involved, and the market opportunity.
What makes YZR Capital different from other VC firms?
YZR Capital combines deep industry expertise with a strong network in the healthcare sector. The firm actively engages with its portfolio companies, providing strategic support and resources to drive innovation and growth.
What is the geographic scope of YZR Capital's investments?
YZR Capital primarily invests in companies across Europe, focusing on those that are addressing healthcare challenges on a pan-European scale.
What is the typical fund size and check size for YZR Capital?
YZR Capital's first fund is €100 million, with check sizes varying based on the stage of investment, typically ranging from pre-seed to growth equity.
What kind of post-investment involvement does YZR Capital have?
The firm provides ongoing support to its portfolio companies, leveraging its industry connections and expertise to enhance operational efficiencies and facilitate access to resources that drive growth.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.